Recursion Pharmaceuticals (NASDAQ:RXRX) Q3 2026 Earnings Call

Recursion Pharmaceuticals (NASDAQ:RXRX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.

Tue, November 3, 2026 at 8:00 AMpublished
Recursion Pharmaceuticals (NASDAQ:RXRX) Q3 2026 Earnings Call
Company
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Period
Q3 2026 earnings call
Date
Tue, Nov 3, 2026, 8:00 AM ET
Results news release
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and… · Mon, Nov 2, 2026

On 6ix: 6ix.com/event/recursion-pharmaceuticals-inc-rxrx-q3-2026-earnings-call

Latest news releases

Companies on this call

More from Recursion Pharmaceuticals, Inc.